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The intestinal microbiota plays an important role in the development of post-natal gastrointestinal functions of the
host. Recent advances in our capability to identify microbes and their function offer exciting opportunities to
evaluate the complex cross talk between microbiota, intestinal barrier, immune system and the gut-brain axis. This
review summarizes these interactions in the early colonization of gastrointestinal tract with a major focus on the
role of intestinal microbiota in the pathogenesis of feeding intolerance in preterm newborn. The potential benefit
of early probiotic supplementation opens new perspectives in case of altered intestinal colonization at birth as
preventive and therapeutic agents.
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In the human gut resides the microbiota, a large and di-
verse community of microorganism, dominated by bac-
teria, known to have a critical role in the evolution of the
intestinal functions and in overall health of the host [1].
The bacterial cells far outnumber the human cells of the
host that harbors them and the total amount of genes in
the various species represented in our indigenous micro-
bial communities is estimated about 2–4 million, exceed-
ing the number of our human genes >100-fold [2].
Through expression of this exceptional quantity of genes,
whose totality is termed the “microbiome”, intestinal bac-
teria can execute numerous enzymatic reactions that the
mammalian host is not able to catalyze. This is the reason
why the microbiota is now considered as an “organ within
an organ”, with its own functions: it modulates expression
of genes involved in mucosal barrier fortification, angio-
genesis and postnatal intestinal maturation. It also has a
critical role in supporting normal digestion and affects en-
ergy harvest from the diet and energy storage in the host,
fermenting unused energy substrates to short chain fatty
acids (SCFAs) [3].* Correspondence: f.indrio@neonatologia.uniba.it
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reproduction in any medium, provided the orMicrobial functions are intimately strain-related and
even different strains of a single species may differ in the
effects they produce.
Primary colonization of the gut can be regarded as an
important stage of development of intestinal functions
and the transference of the microbiota at birth from ma-
ternal vaginal and intestinal flora comprises a hereditary
succession of a parallel genome [4].
A large interface between the external environment and
the mammalian host is represented by the intestinal epi-
thelium. The complex cross-talk between the gut and its
microbial content is a normal part of development and
plays a determinant role in the capacity to distinguish po-
tentially dangerous from harmless bacterial and food anti-
gens. This function requires sophisticated sensor systems
to be responsive to a wide variety of microbial and food
antigens that transits or populates the GI tract [5].
The intestinal microbiota possesses an immunomodu-
latory capacity, affecting a variety of signaling pathways
with modulation of proper immune, inflammatory and
allergic responses. An imbalance of normal intestinal
microbiota, or the host response to such an imbalance
are considered to be involved in the pathogenesis of a
variety of intestinal disorders [6].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Newborn infants exit the uterus and enter an extrauterine
environment filled with microbes. The gastrointestinal
tract of a normal fetus is generally thought to be sterile.
However, recent studies using molecular techniques are
suggesting that the fetal intestine may be exposed to mi-
crobes via swallowing of colonized amniotic fluid [7,8].
Occult microbes in amniotic fluid may be associated with
preterm labor and premature rupture of membranes.
Despite ongoing studies to determine the qualitative
and the quantitative state of microorganisms in amniotic
fluid, this new aspect of fetal gut colonization remains a
largely unexplored area. The finding of microbial DNA
in meconium of preterm infants offers the opportunity
to further explore the intraamniotic microbial milieu of
newly born infants [9].
During delivery, bacteria from maternal vaginal and in-
testinal microbiota in vaginal birth or from maternal skin
surface and the surrounding environment in cesarean
section, colonize the gut of the newborn with different mi-
crobial strains [10]. A great number of bacteria, both bene-
ficial and harmful, can colonize the gastrointestinal tract.
Some bacteria family are common pathogens, such as
Clostridiacea, Pseudomonadaceae and Staphylococcaceae.
Others can be either pathogenic or beneficial such as
Bacterioidaceae and Enterobacteriaceae. Still others are
thought to be primarily beneficial, most commonly Lacto-
bacillaceae and Bifidobacteriaceae.
Although vary studies have been performed to sample
the general composition of the infant gut, the real micro-
bial biodiversity still remain controversial and unknown;
caution must be applied in the interpretation of the differ-
ent results obtained by both culture-dependent and meta-
genomic techniques, due to technical biases [11].
According to delivery mode, caesarean section de-
livered newborns, that are deprived of contact with
maternal vaginal microbiota, have a deficiency of strict
anaerobes with lower numbers of E. coli, Bacteroides
and Bifidobacteria and an higher presence of facultative
anaerobes such as Clostridium species, compared with
vaginally born infants [12].
Also infant’s gestational age at birth seem to have signifi-
cant effects on the intestinal microbiota [13]. It’s now clear
that the pattern of bacterial colonization in the preterm
neonatal gut differs from that in the healthy, full-term
neonatal gut. This aberrant colonization, mostly due to
the routine use of sterile formula and antibiotics in neo-
natal intensive care unit (NICU), could have a central role
in feeding intolerance and in development of necrotizing
enterocolitis (NEC), a devasting disease affecting primarily
premature infants [14].
Afterwards, in the early stage of life, the composition
of the intestinal microbiota undergoes major modifica-
tions, mostly influenced by the feeding pattern [10].Gastrointestinal flora composition differs substantially in
breast-fed infants and formula-fed infants because of the
differences in composition between human milk and
standard infant formula. For example, breast milk-fed in-
fant microbiota is composed by an increased number of
bifidobacteria and lactobacilli, whereas formula-fed infant
microbiota has more enterococci and enterobacteria. This
difference is thought to be due to the breast milk compos-
ition of molecules with antimicrobial activity and prebiotic
oligosaccharides, thought to have a beneficial role for the
infant [15,16]. Furthermore, there is accumulating evidence
that human milk is not sterile but contains maternal de-
rived bacterial molecular motifs that are thought to influ-
ence the newborn’s immune system development. This
procedure is called “bacterial imprinting”, and its overall
biological effect requires further study [17,18].
The initial bacterial colonization after birth, and its
change according to environment, nursing, weaning and
drugs, plays a crucial function in the final development of
the gut with large shifts in the relative abundances of taxo-
nomic groups. The composition of microbiota undergoes
significant changes in infancy. Some authors observed a
gradual increase in diversity over time, with a discrete steps
of bacterial succession according to similar life events [19].
The gut interacts with intestinal bacteria to mature
protective mechanisms against harmful molecules (via
improving barrier gut functions, motility and immune
stimulation) and appropriate, non-exaggerated responses
versus commensal bacteria and nutrients (via immune-
modulation and immune-tolerance) [20]. The mecha-
nisms of this interaction between host and bacteria are
increasingly being unrevealed. An aberrant bacterial
colonization may be a coexisting factor in feeding intole-
rance in newborn. The exact effects of bacterial coloni-
zation in pathophysiology of feeding intolerance is based
on the post-natal uncorrect ontogenesis of the intestinal
barrier, of the immune responses and of sensori-motor
functions of the gut [21] Figure 1.Microbiota modulation on development of
gastrointestinal functions
Microbiota and intestinal barrier function
Microbial intestinal content plays an important part in
the evolution of gastrointestinal structure via direct
interaction with mucosal cell, immune cells and neur-
onal endings. To support this statement, some studies
have shown structural aberration affecting free-germ
mice: greatly enlarged cecum, reduced intestinal surface
area, decreased epithelial cell turnover, smaller Peyer’s
Patches and disordered gut-associated lymphoid tissue
and smaller villous thickness [22,23]. This morphological
consequences of growing up germ-free result in gastro-
intestinal functional disorders.
Figure 1 Intestinal function and microbiota. Commensal bacteria inhabiting the human intestine participate in the development and
maintenance of gut immunologic, sensory and motor functions. Under normal conditions, the gastrointestinal tract provides a stable habitat for
commensal bacteria that supports its structural and functional integrity. The ENS influence the gut directly with the activity related to the
contraction and indirectly influencing the cells of the gut immune system. The functional bidirectional interaction act via neuroimmune peptide
receptor on immune cells and on several receptor for immune mediators expressed on enteric nerves. Immune cells release mediators in
response to neural stimuli.
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rier and, consequently, its functions. Studies have shown
that certain bacteria (E. coli, Bifidobacterium, Lactobacillis)
increase intestinal epithelial cell survival by inhibiting the
activation of the epithelial cell pro-apoptotic pathway asso-
ciated with pathogenic bacteria [24]. The commensal
microbiota is also involved in maintenance of barrier func-
tion inducing an increased epithelial cell proliferation and
enhancing intestinal epithelial integrity, through transloca-
tion of the tight junction proteins and up-regulation of
genes involved in desmosome maintenance [25]. Finally,
commensal bacteria regulate development of intestinal vil-
lus vascular architecture [26].
Surface enterocytes can recognize bacterial products via
a highly conserved family of pathogen-associated molecu-
lar pattern (PAMP) receptors called Toll-like receptors
(TLR). Each of these receptors recognizes a specific bac-
terial product.Binding of any of this receptors leads to activation of
nuclear factor-κB (NF-κB), a group of proteins that start
the transcriptional process of a wide amount of genes.
Despite commensal bacteria interference with patho-
genic infections through effects on intestinal mucosa
structure, the prevention of colonization by pathogens is
achieved in large part by competing for nutrients and re-
ceptors, by production of anti-microbial compounds and
by triggering the expression of multiple cell-signaling
process that can limit the release of virulence factors.
The intestinal mucosa barrier is composed by both non-
specific defensive mechanisms, such as intestinal motility,
mucus secretion, gastric acids and pancreatic enzymes,
and specific immune mechanisms that prevent the transit
of external and unprocessed antigens across the gastro-
intestinal barrier [27].
The gut-barrier faces important challenges: to prevent
pathogens and harmful elements of the gut lumen from
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allow the absorption of nutrients; and finally to promote
passage of molecules and information between gut lumen
and the components of the endocrinal, neuronal, immunal
routes implicated in maintenance of homeostasis.
Exposed to trillions of microbes and countless food
antigens of the gut lumen, the intestinal mucosa is inces-
santly tasting luminal elements and promoting molecu-
lar modification at its frontier to respond in different
way to commensal bacterial or to pathogens.
The early microbial composition of the human gastro-
intestinal tract has long-lasting functional effects, affect-
ing the postnatal immune system development and an
aberrant early colonization that may provoke difficulty
in the capacity to distinguish potentially dangerous from
harmless antigens. A reduced or a abnormal microbial
colonization during first months of life would also pro-
voke a slower postnatal maturation of epithelial cell bar-
rier functions with a consequential altered permeability
that facilitates the invasion of pathogens and foreign or
harmful antigens [28].
An abnormal microbial colonization could finally lead
to mucosal inflammation that plays a pivotal function in
the development of feeding intolerance [29].
Microbiota and gastrointestinal mucosal immunology
The human immune system includes the innate immun-
ity, that has a standardized response to all adverse agents,
and the adaptative immunity, that recognize specifically
each microorganism and have a specific response and
memory. With regards to newborns, we have also to men-
tion the immunity passively acquired by trans-placental
transport of maternal immunoglobulin G in utero and
from human milk secretory IgA antibody after birth. Since
the intestinal mucosa constantly exposed to antigenic
stimulation, the protective function of the gut requires
different factors to stimulate either innate and adaptive
immune response, in a complex and well regulated net of
tolerance-inducing mechanisms residing in the GALT
(gut associated lymphoid tissue), the most extensive
lymphoid system of the human body.
GALT is formed by both inductive (Peyer’s patches) and
effector sites (lamina propria and sub-epithelial cells). It
works as a containment system that prevents the transit
of external and unprocessed, potentially harmful, antigens
across the intestinal barrier but is also constantly in con-
tact with the microbiota and with food antigens.
Germ free studies have revealed that the microbiota is
one of the most important factor for the development of
the GALT [30]. GALT prevents potentially harmful intes-
tinal antigens through polymeric immunoglobulin A (IgA)
secretion and modulates the tolerance versus luminal anti-
gens through processes that involve specific cytokine and
peculiar population of cells. This fundamental entericfunction, known as oral tolerance, is based on the inter-
action between the luminal content, the intestinal epithe-
lium and the tolerogenic dendritic cells (DCs) from
mesenteric lymphonodes of the GALT [31]. Oral tolerance
is able to avoid inflammatory response against food pro-
teins and self aggression against the host’s own resident
intestinal bacterial microbiota through the establishment
of a tolerogenic mechanism on CD4+ T cell naïve that
suppress the expression of T effector cells (Th1 and Th2)
and stimulate the expansion of regulatory T cells (Tregs)
by secreting cytokines such as IL-10 and TGFβ. M cells
and DCs of the GALT can in fact sample the microbial
milieu: M cells efficiently take up in lumen and transport
in the lamina propria a variety of microorganisms and
antigens via active vesicular transport across the epithe-
lium. Lamina propria DCs process antigens from intes-
tinal lumen by sending dendrites between enterocytes and
present them to T naïve cells.
In the lamina propria, isolated and epithelium-associated
lymphoid follicles are proposed to be local sites in gut for
interaction between subepithelial antigen-presenting cells,
antigens and lymphocytes. In this setting, DCs modulate
immune responses through activation of signaling events
leading to improve expression of factors, such as cytokines
and chemokine that recruit and regulate the phenotype
and functions of immune T cells [32]. Antigens are pre-
sented by dendritic cells in the contest of MHC class II
molecules to naïve T lymphocytes. Intestinal responses of
the naïve T cells to these either food or bacterial signals are
generally described in terms of two classes of CD4+ T cells,
defined by their cytokine production: T helper type 1 that
modulate cell-mediated immunity by secreting INFγ and
TNFα; and T helper type 2 that modulate humoral im-
munity by secreting IL-4 and IL-6. In a non-diseased state
there is a tight regulation of these cytokines.
The immature immune system of newborn is known to
have a Th2 bias. The postnatal gut colonization makes an
appropriate shift towards a Th1 response that results in a
balance of the system. Microbial colonization influences
toll-like receptors on gut immune cells that recognize
PAMPs and modulate both intestinal innate and an appro-
priate adaptive immune response, according to the charac-
teristics of microbial strain (commensal or pathogen).
Different lactic acid bacteria as Lactobacillus and
Bifidobacterium have been shown to determine a pro-
portioned T helper cell response, forbidding a T cell un-
balance (Th2 > Th1 or Th1 > Th2) that may conduce to
clinical disease [33].
These findings demonstrate that the intestinal micro-
flora and its qualitative differences in composition might
affect immunologic homeostasis. The balance between
microbiota, immune response and tolerance mechanisms
is fundamental for a healthy intestine, and inappropriate
relationship due to an abnormal colonization may result
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gastrointestinal disease in childhood.
Microbiota-gut-brain-axis
In the past few years, growing evidence supports the im-
portance of microbiota in the maturation and modula-
tion of gut sensorimotor functions. Gut sensory and
motor function are under control of the gut-brain axis, a
complex bidirectional communication system that exists
between the central nervous system and the gastrointes-
tinal tract. Microbiota can interact with this axis emit-
ting and receiving a multiplicity of signals to and from
the brain. This has been reflected in the form of a revised
nomenclature to the more inclusive brain-gut-microbiota
axis and a sustained research effort to establish how com-
munication along this axis contributes to both normal and
pathological condition [34].
The brain can influence microbiota composition indir-
ectly through modifications in gastrointestinal motility, se-
cretion, and intestinal permeability, or directly, via citokines
released into the gut lumen from enterochromaffin cells,
neurons and immune cells of lamina propria. Through the
removal of exuberant bacteria from the lumen, intestinal
motility is considered one of the most important control
systems of the intestinal microbiota, On the other hand,
enteric microbiota also play a role in the development and
sustenance of both sensory and motor gut functions,
through communication with the brain that occurs indir-
ectly through interaction with epithelial-cell and receptor-
mediated signaling and directly through stimulation of
neuronal cells in the lamina propria, when intestinal per-
meability is increased [35].
Integral to these communications are enterochromaffin
cells, which serve as bidirectional transducers that modu-
late interrelationship between the gastrointestinal lumen
and the nervous system [36]. Enterochromaffin cells are
innervated by the sensory fiber of vagus nerve. Gut micro-
biota influence on enterochromaffin cells suggest a role in
the regulation of visceral pain. The correct mechanisms of
action of such effect currently remain unclear. Further-
more, evidence for combination of neural, immune and
endocrine effects emerges from studies [37].
An immature ontogenesis of the bidirectional inter-
relation between the enteric microbiota and the nervous
system, due to an aberrant colonization after birth, could
affect the pathophysiology of feeding intolerance in pre-
term newborn and of different childhood functional
gastrointestinal disease later in life [38].
Microbiota and feeding intolerance in preterm newborn
Disturbance of normal gastrointestinal ontogenesis, early
postnatal stress, different pattern of gastrointestinal
colonization, changes in the microbiota induced by in-
fection or early use of antibiotics in Neonatal IntensiveCare Unit (NICU), or other events, perturb physiologic
inflammation and gut physiology, resulting in an aber-
rant activation of intestinal peristalsis and gut-brain axis
[39]. Aberrant intestinal functions development are the
major determinant for feeding intolerance (FI), a major
problem in NICU. FI is defined as the inability to digest
enteral feedings and may be considered as a predictive
value for a developing NEC [40]. FI occurs most com-
monly in very low birth weight (VLBW) infants, indicating
a deficiency in the developmental pattern of gastrointes-
tinal tract with decreasing gestational age (GA). Newborns
require structural and functional maturation of gastro-
intestinal tract for the digestion and absorption of the
nutrient elements from colostrum and breast milk. A
complete intestinal motor function development includes
suck - swallow coordination, gastroesophageal sphincter
tone continence, adequate gastric emptying and intestinal
peristalsis. Term newborns are able to acquire adequate
quantities of nutrients to promote the rapid growth that
occurs shortly after birth. However, half of preterm infants
are delayed in achieving full enteral feeding volumes and
present reflux, gastric residual and constipation due to
delayed gastric emptying, prolonged intestinal transit,
abdominal distension, and delayed passage of meconium,
all of which reflex gastrointestinal functions immaturity
[41]. There are few studies available about the fetal onto-
genesis and the neonatal early adaptation of motility and
mucosal barrier functions of the human gut [42-44]. Func-
tional components of the human gastrointestinal tract do
not evolve simultaneously: in facts, althought anatomical
differentiation of human gut is usually achieved within 20 -
weeks of gestation, the functional maturation is postponed
over time and require an organized peristalsis and a coor-
dinated sucking and swallowing reflexes, that are not
extabished, respectively, until 29–30 weeks and 32–34 -
weeks of gestations [45]. As illustrated before, the early
composition of the intestinal microbiota at birth can influ-
ence the correct ontogenesis of gut barrier, motor and
immune functions through a complex neuroendocrine
cross-talk [46]. Thus, an appropriate colonization of the
gastrointestinal tract after birthis likely to play an import-
ant role in the final development of gut functions. Prema-
ture infants have an abnormal colonization, tend to
colonize with fewer bacteria, are routinely administered
antibiotics, are often born via caesarian section, and are
exposed to highly pathogenic institutional organisms
[47,48]. Examining the intestinal bacteria present in pre-
mature infants may be an important determinant in the
pathogenesis of feeding intolerance and necrotizing en-
terocolitis (NEC) [49]. Using advanced technologies and
stool samples studies have shown that infants who develop
NEC have significantly less bacterial diversity in their in-
testinal microbiota with presence of certain pathogenic
bacteria and the lack of protective bacteria [50,51].
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biotics early in life may result in immune dysregulation,
aberrant barrier functions, and alterated gut sensori-
motor functions that, in susceptible individuals, may
lead to some disease states after birth or later in life. Ef-
forts to optimize the intestinal microbiota colonization
at birth in neonates who are born by caesarean delivery,
born preterm, exposed to antibiotics and/or fed with
infant-sterile-formulas, have increased the interest in
early probiotics supplementation. Introducing probiotic
to preterm infants has been postulated to enhance en-
teral feeding, prevent NEC and avoid overgrowth of
pathogenic organism. Probiotics are live microbes that
provide health benefits to the host when dispensed in ad-
equate doses. Many strains that are part of the human
intestinal microbiota could be considered as potential
probiotics but microorganisms used in prevention and
treatment of pediatric clinical diseases are typically mem-
bers of the genera lactobacillus and bifidobacterium, fol-
lowing the natural evolution of the microbial colonization
in a healty term breast-fed baby.
Conclusion
The intestine serves as a vast interface between our in-
ternal milieu and external environments. Evidence is
rapidly accumulating that the microbes residing within
the intestinal tract play major roles in the ontogenesis of
the immune system, and interact with the gut as well as
the central nervous systems.
An aberrant microbial colonization with consequential
immaturity in development of immune and neuronal pat-
tern of gastrointestinal tract may be a coexisting cause of
feeding intolerance. Abnormal colonization should con-
stantly be kept in mind as an important environmental
factor that predisposes to disease also later in life.
It is emphasized that the perinatal period most probably
corresponds to a critical time at which “set points” are
imprinted. More needs to be known about normal and
healthy colonization patterns in newborns to promote
these patterns and to avoid perturbations that result in
lifelong disease.
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